Skip to main content
Premium Trial:

Request an Annual Quote

SGB, Yulex Collaborate on Genomic Program to Develop Guayule as Biorubber Source

NEW YORK (GenomeWeb News) – SGB and Yulex today said they will be collaborating on the creation of a genomics and molecular breeding program to accelerate the crop improvement of guayule as a sustainable source of biorubber.

The collaboration seeks to develop guayule as a replacement for tropical or petroleum-based rubber for medical, consumer, and industrial markets. Guayule is an industrial crop that does not compete with food or fiber crops. It requires low inputs and is a renewable source of natural rubber.

Financial and other terms of the deal were not disclosed.

As part of its work, SGB will use a non-genetically modified organism technology platform that combines breeding and selection with genomic technologies, such as high-throughput genotyping, genome-wide trait association studies, genomic selection, and proprietary plant redomestication methods, the partners said.

SGB will identify genetic markers associated with increased yields, and then use them "to produce new cultivars that express that yield under commercial conditions."

The San Diego-based agricultural biotechnology firm also will implement new breeding strategies to hasten the development of "improved cultivars with higher rubber yield productivity, consistency, and increased stress tolerance."

"Deciphering the genetic relationships and ploidy levels residing within guayule germplasm enables advanced breeding strategies which will result in optimized regional productivity, thus expanding guayule's global footprint through the development of new varieties that produce high yields of latex and rubber under diverse environmental conditions," SGB Vice President of Technology Eric Mathur said in a statement.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.